S&P 500   4,267.52
DOW   33,665.02
QQQ   348.82
Stock market today: Asian shares slip following technology selloff on Wall Street
BREAKING: Tiny biotech successfully treats blindness (Ad)
Tesla: How and Why It Gets To $300
Don't Overlook Hidden Gem Kinsale As Rallies To New Highs
Famous Wall Street Crash System Flashes RED (Ad)
AI-powered IoT Automation is Driving Samsara To New Highs
What is a Growth Stock Mutual Fund?
Famous Wall Street Crash System Flashes RED (Ad)
Sprinklr Gets Targets Raised By Analysts, Here's Why
Time To Buy Uranium? Cameco Is The Top Pick
S&P 500   4,267.52
DOW   33,665.02
QQQ   348.82
Stock market today: Asian shares slip following technology selloff on Wall Street
BREAKING: Tiny biotech successfully treats blindness (Ad)
Tesla: How and Why It Gets To $300
Don't Overlook Hidden Gem Kinsale As Rallies To New Highs
Famous Wall Street Crash System Flashes RED (Ad)
AI-powered IoT Automation is Driving Samsara To New Highs
What is a Growth Stock Mutual Fund?
Famous Wall Street Crash System Flashes RED (Ad)
Sprinklr Gets Targets Raised By Analysts, Here's Why
Time To Buy Uranium? Cameco Is The Top Pick
S&P 500   4,267.52
DOW   33,665.02
QQQ   348.82
Stock market today: Asian shares slip following technology selloff on Wall Street
BREAKING: Tiny biotech successfully treats blindness (Ad)
Tesla: How and Why It Gets To $300
Don't Overlook Hidden Gem Kinsale As Rallies To New Highs
Famous Wall Street Crash System Flashes RED (Ad)
AI-powered IoT Automation is Driving Samsara To New Highs
What is a Growth Stock Mutual Fund?
Famous Wall Street Crash System Flashes RED (Ad)
Sprinklr Gets Targets Raised By Analysts, Here's Why
Time To Buy Uranium? Cameco Is The Top Pick
S&P 500   4,267.52
DOW   33,665.02
QQQ   348.82
Stock market today: Asian shares slip following technology selloff on Wall Street
BREAKING: Tiny biotech successfully treats blindness (Ad)
Tesla: How and Why It Gets To $300
Don't Overlook Hidden Gem Kinsale As Rallies To New Highs
Famous Wall Street Crash System Flashes RED (Ad)
AI-powered IoT Automation is Driving Samsara To New Highs
What is a Growth Stock Mutual Fund?
Famous Wall Street Crash System Flashes RED (Ad)
Sprinklr Gets Targets Raised By Analysts, Here's Why
Time To Buy Uranium? Cameco Is The Top Pick
NYSE:MJN

Mead Johnson Nutrition (MJN) Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$89.98
$89.98
50-Day Range
N/A
52-Week Range
$69.25
$94.40
Volume
N/A
Average Volume
3.24 million shs
Market Capitalization
N/A
P/E Ratio
24.25
Dividend Yield
N/A
Price Target
N/A

MJN stock logo

About Mead Johnson Nutrition (NYSE:MJN) Stock

Mead Johnson Nutrition Company (Mead Johnson) is a pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, children's nutrition and other nutritional products. The Company operates through three segments: Asia, Latin America and North America/Europe. Its product portfolio includes routine and specialty infant formulas, children's milks and milk modifiers, dietary supplements for pregnant and breastfeeding mothers, pediatric vitamins, and products for pediatric metabolic disorders. The Company's Enfa family of brands, including Enfamil infant formula, is a brand franchise in pediatric nutrition. Its product portfolio addresses a range of nutritional needs for infants, children and expectant and nursing mothers. The Company marketed its portfolio of more than 70 products to mothers, healthcare professionals and retailers in more than 50 countries in Asia, North America, Latin America and Europe, as of December 31, 2016.

Receive MJN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mead Johnson Nutrition and its competitors with MarketBeat's FREE daily newsletter.

MJN Stock News Headlines

Mead Johnson Nutrition
66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
Baby Food Pediatric Nutrition Market by 2031
Mead Senior High School
66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
As Lake Mead dries up, mysteries are being exposed
IPOs Surged 103% in 2009
See More Headlines


MJN Company Calendar

Last Earnings
4/27/2017
Today
6/08/2023

Industry, Sector and Symbol

Industry
N/A
Sub-Industry
Packaged Foods & Meats
Sector
N/A
CUSIP
58283910
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Optionable
Beta
N/A

Key Executives

  • Peter Kasper Jakobsen
    President, Chief Executive Officer, Director
  • Michel M.G. Cup
    Chief Financial Officer, Executive Vice President
  • Charles M. Urbain
    Chief Operating Officer, Executive Vice President
  • Patrick M. Sheller
    Senior Vice President, General Counsel, Secretary
  • James E. Shiah
    Senior Vice President, Corporate Controller
  • James Jeffrey Jobe
    Senior Vice President - Technical Operations
  • Ian Eric Ormesher
    Senior Vice President- Global Human Resources
  • Dirk Hondmann Ph.D.
    Chief Scientific Officer
  • James M. Cornelius
    Non-Executive Chairman of the Board
  • Elliot Sigal M.D. Ph.D.
    Director













MJN Stock - Frequently Asked Questions

How were Mead Johnson Nutrition's earnings last quarter?

Mead Johnson Nutrition CO (NYSE:MJN) released its earnings results on Thursday, April, 27th. The company reported $0.80 EPS for the quarter, topping the consensus estimate of $0.79 by $0.01. The company had revenue of $883.50 million for the quarter, compared to analyst estimates of $911.63 million. The company's revenue for the quarter was down 8.2% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.87 earnings per share.

Is Mead Johnson Nutrition a good dividend stock?

Mead Johnson Nutrition (NYSE:MJN) pays an annual dividend of $1.65 per share and currently has a dividend yield of 0.00%. The dividend payout ratio is 44.47%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for MJN.

What other stocks do shareholders of Mead Johnson Nutrition own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Mead Johnson Nutrition investors own include Ford Motor (F), Gilead Sciences (GILD), Caterpillar (CAT), CenterPoint Energy (CNP), General Electric (GE), Procter & Gamble (PG), QUALCOMM (QCOM), AT&T (T), Bristol-Myers Squibb (BMY) and Cisco Systems (CSCO).

What is Mead Johnson Nutrition's stock symbol?

Mead Johnson Nutrition trades on the New York Stock Exchange (NYSE) under the ticker symbol "MJN."

What is Mead Johnson Nutrition's stock price today?

One share of MJN stock can currently be purchased for approximately $89.98.

How can I contact Mead Johnson Nutrition?

Mead Johnson Nutrition's mailing address is 225 N Canal St Fl 25, CHICAGO, IL 60606-1791, United States. The official website for the company is www.meadjohnson.com. The company can be reached via phone at +1-312-4665800.

This page (NYSE:MJN) was last updated on 6/8/2023 by MarketBeat.com Staff

My Account -